1-6 of 6
Abdul Al-Tourah
Close
Sort by
Journal Articles

Autologous Stem Cell Transplantation Is Superior to Myeloablative Allogeneic SCT as a Salvage Therapy for Patients with Refractory/Relapsed Transformed Lymphoma

Khaled M Ramadan, MB, Joseph M. Connors, Abdul Al-Tourah, Randy D. Gascoyne, Kevin W. Song, Michael J. Barnett, Stephen H. Nantel, MD, FRCPC, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Julye Lavoie, MD, Donna L. Forrest, Donna E. Hogge, MD, PhD, Nicholas Voss, MD, Ryan Brinkman, PhD, Yasser R. Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Clayton A. Smith, Cynthia L. Toze, MD, FRCP(C)
Journal: Blood
Blood (2008) 112 (11): 4459.
https://doi.org/10.1182/blood.V112.11.4459.4459
Published: 2008
Journal Articles

Combined FOXP3 + and PD1 + T Cell Density and Architectural Patterns Predict Overall Survival and Risk of Transformation in Uniformly Treated Patients with Follicular Lymphoma

Pedro Farinha, Giovanna Roncador, Abdul Al-Tourah, Joseph M Connors, Randy D Gascoyne
Journal: Blood
Blood (2008) 112 (11): 2815.
https://doi.org/10.1182/blood.V112.11.2815.2815
Published: 2008
Journal Articles

Comparison of Outcome Between Refractory/Relapsed De Novo Diffuse Large B-Cell and Transformed Lymphoma Using Related and Unrelated Allogeneic Hematopoietic SCT.

Khaled M Ramadan, MB, Kevin W. Song, Joseph M. Connors, Abdul Al-Tourah, Randy D. Gascoyne, Michael J. Barnett, Stephen H. Nantel, MD, FRCPC, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Julye Lavoie, MD, Donna L. Forrest, Donna E. Hogge, MD, PhD, Nicholas Voss, MD, Ryan Brinkman, PhD, Yasser R. Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Clayton A. Smith, Cynthia L. Toze, MD, FRCP(C)
Journal: Blood
Blood (2008) 112 (11): 2173.
https://doi.org/10.1182/blood.V112.11.2173.2173
Published: 2008
Journal Articles

Salvage Therapy with Allogeneic Stem Cell Transplantation Results in Better Outcome for Patients with Relapsed/Refractory Follicular Lymphoma Compared to Those with Transformed Non-Hodgkin Lymphoma: A Population-Based Comparative Study.

Khaled M Ramadan, MB, Joseph M. Connors, Abdul Al-Tourah, Randy D. Gascoyne, MD, Kevin W. Song, Michael J. Barnett, Stephen H. Nantel, MD, FRCPC, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Julye Lavoie, MD, Donna L. Forrest, Donna E. Hogge, MD, PhD, Nicholas Voss, MD, Ryan Brinkman, PhD, Yasser R. Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Clayton A. Smith, Cynthia L. Toze, MD, FRCP(C)
Journal: Blood
Blood (2008) 112 (11): 975.
https://doi.org/10.1182/blood.V112.11.975.975
Published: 2008
Journal Articles

The Architecural Pattern of FOXP3+ T Cells Predicts Risk of Transformation in Patients with Follicular Lymphoma (FL).

Pedro Farinha, MD, Abdul Al-Tourah, MD, Joseph M. Connors, MD, Randy D. Gascoyne, MD
Journal: Blood
Blood (2007) 110 (11): 358.
https://doi.org/10.1182/blood.V110.11.358.358
Published: 2007
Journal Articles

Insights into Disease Evolution of Transformed Follicular Lymphoma Derived from Cytogenetics.

Nathalie A. Johnson, MD, Abdul Al-Tourah, MD, Douglas E. Horsman, MD, Joseph M. Connors, MD, Randy D. Gascoyne, MD
Journal: Blood
Blood (2005) 106 (11): 604.
https://doi.org/10.1182/blood.V106.11.604.604
Published: 2005